Last edition
News about Market
Morepen Begins Commercial Supplies under INR 825 Crore CDMO Contract
Morepen has started commercial supplies under its INR 825 crore CDMO mandate, completing the first INR 50 crore dispatch in Q1 FY2026-27 and strengthening its contract manufacturing business.
Market | 01/07/2026 | By News Bureau
Aurobindo Pharma USA Completes Acquisition of Lannett Company
Aurobindo Pharma USA has completed the acquisition of Lannett Company after securing approval from the US Federal Trade Commission. Effective June 29, 2026, Lannett will operate as Lannett Company LLC, with the combined entity aiming to strengthen the supply of essential medicines and enhance value for patients and customers.
Market | 30/06/2026 | By News Bureau
Universe Pharmaceuticals to Acquire Patent Holding Firm in USD 10.75 Million Share Deal
Universe Pharmaceutical’s acquisition will strengthen Best Praise International's intellectual property portfolio with five China-based pharmaceutical patents, supporting its long-term strategy to expand research, product development and commercial opportunities in elderly healthcare and age-related diseases.
Market | 30/06/2026 | By News Bureau | 135
Strides Pharma Science has sold a majority stake in its subsidiary, Pivot Path, to an Ascent Capital-led investor consortium for INR 100 crore, alongside a fresh INR 50 crore capital infusion that will support the company's expansion as an independent life sciences and digital transformation services provider.
Market | 29/06/2026 | By News Bureau
BDR Pharma Launches Xatronem-AV to Combat Multidrug-Resistant Gram-Negative Infections
BDR Pharma introduces Xatronem-AV, a next-generation antibacterial therapy for serious multidrug-resistant Gram-negative infections.
Market | 26/06/2026 | By News Bureau | 114
Merck KGaA Acquires Bio-Techne to Expand Life Sciences Business
Merck KGaA will acquire Bio-Techne in a USD 11.3 billion deal, strengthening its leadership in life sciences and expanding capabilities across high-growth markets.
Market | 26/06/2026 | By News Bureau
Advanta bioKEMIX Forms Joint Venture with Resolkem to Expand High-Purity Solvent Manufacturing
Resolkem aims to combine advanced manufacturing capabilities with global market access to strengthen supply chains for pharmaceutical, biotechnology and specialty chemical industries.
Market | 25/06/2026 | By News Bureau
The European Commission has approved Trodelvy for first-line treatment of unresectable or metastatic triple-negative breast cancer, offering a new therapeutic option for patients with one of the most aggressive forms of breast cancer.
Market | 25/06/2026 | By News Bureau
Merck Partners with Versant Ventures to Launch Saturnus Bio
Merck has partnered with Versant Ventures to establish Saturnus Bio, advancing precision medicine through gene modulation technologies for rare genetic cardiomyopathies.
Market | 25/06/2026 | By News Bureau
Antengene Licenses ATG-106 to K2 Therapeutics in Strategic Deal
Antengene has granted K2 Therapeutics exclusive global rights to develop and commercialise ATG-106 outside Greater China under a strategic licensing agreement that also includes an option for an undisclosed bispecific T-Cell Engager (TCE).
Market | 24/06/2026 | By News Bureau | 124
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy